131 related articles for article (PubMed ID: 22843926)
21. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
Jpn J Surg; 1988 Nov; 18(6):681-6. PubMed ID: 3150019
[TBL] [Abstract][Full Text] [Related]
22. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: identification of responders incorporating the age factor.
Munemoto Y; Iida Y; Ohata K; Saito H; Fujisawa K; Kasahara Y; Mitsui T; Asada Y; Miura S
Oncol Rep; 2004 Mar; 11(3):623-35. PubMed ID: 14767513
[TBL] [Abstract][Full Text] [Related]
23. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
[TBL] [Abstract][Full Text] [Related]
24. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
25. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1).
Namikawa T; Fukudome I; Ogawa M; Munekage E; Munekage M; Shiga M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Eur J Surg Oncol; 2015 Jun; 41(6):795-800. PubMed ID: 25887287
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
[TBL] [Abstract][Full Text] [Related]
28. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
Ichihashi H; Kondo T; Yamauchi M; Isomatsu T; Nakamura T; Sakabe T; Nakajima T; Ikenaga T; Shiratori T; Taguchi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509
[TBL] [Abstract][Full Text] [Related]
29. [Administration of polysaccharide K (PSK) for stage III rectal cancer in clinical practice].
Ishibashi K; Hokama N; Ishiguro T; Kuwabara K; Okada N; Ohsawa T; Miyazaki T; Yokoyama M; Ishida H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1975-8. PubMed ID: 20037296
[TBL] [Abstract][Full Text] [Related]
30. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Nakazato H; Ichihashi H; Kondo T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):308-18. PubMed ID: 3947108
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
[TBL] [Abstract][Full Text] [Related]
32. [S-1/krestin immunochemotherapy for patients with advanced gastric cancer].
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1921-3. PubMed ID: 22202239
[TBL] [Abstract][Full Text] [Related]
33. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.
Ito G; Tanaka H; Ohira M; Yoshii M; Muguruma K; Kubo N; Yashiro M; Yamada N; Maeda K; Sawada T; Hirakawa K
Exp Ther Med; 2012 Jun; 3(6):925-930. PubMed ID: 22969994
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx.
Go P; Chung CH
J Int Med Res; 1989; 17(2):141-9. PubMed ID: 2656331
[TBL] [Abstract][Full Text] [Related]
35. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
Tamada R; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Nakajima T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):716-22. PubMed ID: 3103540
[TBL] [Abstract][Full Text] [Related]
36. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
Toge T; Yamaguchi Y
Oncol Rep; 2000; 7(5):1157-61. PubMed ID: 10948356
[TBL] [Abstract][Full Text] [Related]
37. Protein-bound polysaccharide K partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer.
Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Sugai H; Akaike H; Fujii H
Oncology; 2008; 74(3-4):143-9. PubMed ID: 18708731
[TBL] [Abstract][Full Text] [Related]
38. [Clinical effects of PSK on esophageal and gastric cancer patients and usefulness of serum levels of glycoproteins and HLA antigens as prognostic indicators].
Ogoshi K; Mitomi T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1443-6. PubMed ID: 2586437
[TBL] [Abstract][Full Text] [Related]
39. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Shibata M; Nezu T; Fujisaki S; Andou K; Tomita R; Fukuzawa M
Dig Surg; 2002; 19(4):255-60. PubMed ID: 12207066
[TBL] [Abstract][Full Text] [Related]
40. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1850-63. PubMed ID: 3929694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
